A line of transgenic mice carrying a chimeric gene composed of human insulin-like growth factor I (IGF-I) coding sequences fused to the mouse metallothionein I promoter was generated to study the effects of chronically elevated exposure to IGF-I. Mice in this line overexpress IGF-I in most tissues studied and have circulating IGF-I levels 1.5 times the normal value. This results in a growth response manifested by a 1.3-fold increase in weight as a result of selective organomegaly without an apparent increase in skeletal growth. In addition, expression of the endogenous GH and IGF-I genes is inhibited. These results are consistent with IGF-I playing an important role in the control of somatic growth. © 1988 by The Endocrine Society.
CITATION STYLE
Mathews, L. S., Hammer, R. E., Behringer, R. R., D’Ercole, A. J., Bell, G. I., Brinster, R. L., & Palmiter, R. D. (1988). Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology, 123(6), 2827–2833. https://doi.org/10.1210/endo-123-6-2827
Mendeley helps you to discover research relevant for your work.